Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tampa, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Akari Therapeutics Plc has filed 729 SEC EDGAR filings since 13 Apr 2012

SEC filing history

Showing 276-300 of 729 matching filings.

Per page
25
Current page
12
6-K File 001-36288

FORM 6-K

Filing date
28 Oct 2022
Reporting date
28 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1 File 333-267840

FORM F-1

Filing date
12 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-460011

D filing

Filing date
27 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251673

424B5

Filing date
14 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
14 Sep 2022
Reporting date
14 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
29 Jul 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
20 Jul 2022
Reporting date
20 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
08 Jul 2022
Reporting date
07 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
05 Jul 2022
Reporting date
05 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
16 Jun 2022
Reporting date
15 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
07 Jun 2022
Reporting date
06 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
20 May 2022
Reporting date
20 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
11 May 2022
Reporting date
11 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
09 May 2022
Reporting date
09 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 20-F File 001-36288

NT 20-F

Filing date
29 Apr 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251673

424B5

Filing date
10 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
10 Mar 2022
Reporting date
09 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
04 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

FORM 6-K

Filing date
28 Feb 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87614

AMENDMENT NO. 3 TO SCHEDULE 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .